{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T21:45:15Z","timestamp":1768513515318,"version":"3.49.0"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.biopha.2017.03.101","type":"journal-article","created":{"date-parts":[[2017,4,18]],"date-time":"2017-04-18T01:16:11Z","timestamp":1492478171000},"page":"786-795","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"special_numbering":"C","title":["The efficacy of donepezil administration on acetylcholinesterase activity and altered redox homeostasis in Alzheimer\u2019s disease"],"prefix":"10.1016","volume":"90","author":[{"given":"Pinar","family":"Atukeren","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahir","family":"Cengiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hakan","family":"Yavuzer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Remise","family":"Gelisgen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esma","family":"Altunoglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sena","family":"Oner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fusun","family":"Erdenen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Damla","family":"Yuceak\u0131n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Himmet","family":"Derici","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ufuk","family":"Cakatay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hafize","family":"Uzun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.biopha.2017.03.101_bib0005","doi-asserted-by":"crossref","first-page":"116","DOI":"10.2174\/1567205012666150204121719","article-title":"Role of environmental contaminants in the etiology of alzheimer's disease: a review, curr","volume":"12","author":"Yegambaram","year":"2015","journal-title":"Alzheimer Res."},{"key":"10.1016\/j.biopha.2017.03.101_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2016.09.057","article-title":"Design, synthesis, in-silico and biological evaluation of novel donepezil derivatives as multi-target-directed ligands for the treatment of Alzheimer's disease","author":"Mishra","year":"2017","journal-title":"Eur. J Med. Chem."},{"key":"10.1016\/j.biopha.2017.03.101_bib0015","doi-asserted-by":"crossref","first-page":"467","DOI":"10.3233\/JAD-2012-120124","article-title":"Antioxidant enzymatic activities in Alzheimer's disease: the relationship to acetylcholinesterase inhibitors","volume":"30","author":"Klugman","year":"2012","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.biopha.2017.03.101_bib0020","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1093\/qjmed\/94.9.485","article-title":"Increased oxidative stress in Alzheimer's disease as assessed with 4-hydroxynonenal but not malondialdehyde","volume":"94","author":"McGrath","year":"2001","journal-title":"QJM"},{"key":"10.1016\/j.biopha.2017.03.101_bib0025","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1750-3639.1999.tb00215.x","article-title":"Oxidative alterations in Alzheimer's disease","volume":"9","author":"Markesbery","year":"1999","journal-title":"Brain Pathol."},{"key":"10.1016\/j.biopha.2017.03.101_bib0030","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1046\/j.1471-4159.1997.68010255.x","article-title":"A role for 4-hydroxynonenal an aldehydic product of lipid peroxidation, in disruption of ion homeostasis and neuronal death induced by amyloid beta-peptide","volume":"68","author":"Mark","year":"1997","journal-title":"J. Neurochem."},{"issue":"2","key":"10.1016\/j.biopha.2017.03.101_bib0035","doi-asserted-by":"crossref","first-page":"553","DOI":"10.3233\/JAD-141797","article-title":"Influence of oxidative stress biomarkers on cognitive decline","volume":"45","author":"Revel","year":"2015","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.biopha.2017.03.101_bib0040","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/S0891-5849(02)00794-3","article-title":"Lipid peroxidation and protein oxidation in Alzheimer's disease brain: potential causes and consequences involving amyloid beta-peptide-associated free radical oxidative stress","volume":"32","author":"Butterfield","year":"2002","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.biopha.2017.03.101_bib0045","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.neulet.2014.12.033","article-title":"Oxidative stress accelerates amyloid deposition and memory impairment in a double-transgenic mouse model of Alzheimer's disease","volume":"587","author":"Kanamaru","year":"2015","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.biopha.2017.03.101_bib0050","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1046\/j.1471-4159.1999.0720771.x","article-title":"Increased DNA oxidation and decreased levels of repair products in Alzheimer's disease ventricular CSF","volume":"72","author":"Lovell","year":"1999","journal-title":"J.Neurochem"},{"key":"10.1016\/j.biopha.2017.03.101_bib0055","doi-asserted-by":"crossref","first-page":"436","DOI":"10.3389\/fncel.2014.00436","article-title":"D. Pratic\u00f2. The 5-lipoxygenase pathway: oxidative and inflammatory contributions to the Alzheimer's disease phenotype","volume":"8","author":"Joshi","year":"2015","journal-title":"Front. Cell Neurosci."},{"key":"10.1016\/j.biopha.2017.03.101_bib0060","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.nrl.2014.10.012","article-title":"Role of genes GSTM1, GSTT1, and MnSOD in the development of late-onset Alzheimer disease and their relationship with APOE*4","volume":"8","author":"de Mendon\u00e7a","year":"2016","journal-title":"Neurologia"},{"key":"10.1016\/j.biopha.2017.03.101_bib0065","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1159\/000358901","article-title":"Oxidative stress, mitochondrial dysfunction and the mitochondria theory of aging","volume":"39","author":"Kong","year":"2014","journal-title":"Interdiscip. Top Gerontol."},{"key":"10.1016\/j.biopha.2017.03.101_bib0070","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1111\/j.1471-4159.2005.03053.x","article-title":"Increased oxidative damage in nuclear and mitochondrial DNA in Alzheimer's disease","volume":"93","author":"Wang","year":"2005","journal-title":"J.Neurochem"},{"key":"10.1016\/j.biopha.2017.03.101_bib0075","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.biopha.2016.06.021","article-title":"Pelargonidin improves memory deficit in amyloid \u03b225-35 rat model of Alzheimer's disease by inhibition of glial activation, cholinesterase, and oxidative stress","volume":"83","author":"Sohanaki","year":"2016","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2017.03.101_bib0080","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.biopha.2016.12.067","article-title":"Riluzole ameliorates learning and memory deficits in A\u03b225-35-induced rat model of Alzheimer's disease and is independent of cholinoceptor activation","volume":"87","author":"Mokhtari","year":"2016","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2017.03.101_bib0085","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jep.2016.04.060","article-title":"Neuroprotective effects of Danggui-Jakyak-San on rat stroke model through antioxidant\/antiapoptotic pathway","volume":"188","author":"Kim","year":"2016","journal-title":"J.Ethnopharmacol"},{"key":"10.1016\/j.biopha.2017.03.101_bib0090","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","article-title":"Clinical diagnosis of Alzheimer\u2019s disease: report of the NINCDSADRDAwork group under the auspices of Department of Health and Human Services Task Force on Alzheimer\u2019s disease","volume":"34","author":"McKhann","year":"1984","journal-title":"Neurology"},{"key":"10.1016\/j.biopha.2017.03.101_bib0095","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"Mini-mental state: a practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.biopha.2017.03.101_bib0100","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1212\/WNL.43.11.2412-a","article-title":"The clinical dementia rating (CDR): current vision and scoring rules","volume":"43","author":"Morris","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.biopha.2017.03.101_bib0105","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1093\/geront\/9.3_Part_1.179","article-title":"Assessment of older people selfmaintaining and instrumental activities of daily living","volume":"9","author":"Lowton","year":"1969","journal-title":"Gerontologist"},{"key":"10.1016\/j.biopha.2017.03.101_bib0110","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0076-6879(94)33041-7","article-title":"Oxidative damage to proteins: spectrophotometric method for carbonyl assay","volume":"233","author":"Reznick","year":"1994","journal-title":"Methods. Enzymol."},{"key":"10.1016\/j.biopha.2017.03.101_bib0115","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1667\/RR1454.1","article-title":"Chronic oxidative stress as a mechanism for radiation nephropathy","volume":"171","author":"Lenarczyk","year":"2009","journal-title":"Radiat. Res."},{"key":"10.1016\/j.biopha.2017.03.101_bib0120","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/0003-2697(68)90092-4","article-title":"Estimation of total protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman's reagent","volume":"25","author":"Sedlak","year":"1968","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.biopha.2017.03.101_bib0125","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.cca.2012.01.038","article-title":"G. Jonsson. Improved detection of advanced oxidation protein products in plasma","volume":"413","author":"Hanasand","year":"2012","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.biopha.2017.03.101_bib0130","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.exger.2013.11.014","article-title":"Advanced oxidation protein products accelerate bone deterioration in aged rats","volume":"50","author":"Zeng","year":"2014","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.biopha.2017.03.101_bib0135","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/389629","article-title":"Oxidative modification of proteins in pediatric cystic fibrosis with bacterial infections","author":"Sadowska-Bartosz","year":"2014","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.biopha.2017.03.101_bib0140","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.clinbiochem.2007.12.008","article-title":"Prooxidant-antioxidant balance as a new risk factor in patients with angiographically defined coronary artery disease","volume":"41","author":"Alamdari","year":"2008","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.biopha.2017.03.101_bib0145","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0076-6879(99)99005-5","article-title":"Ferric reducing\/antioxidant power assay: direct measure of total antioxidant activity of biological fluids and modified version for simultaneous measurement of total antioxidant power and ascorbic acid concentration","volume":"299","author":"Benzi","year":"1999","journal-title":"Methods. Enzymol."},{"key":"10.1016\/j.biopha.2017.03.101_bib0150","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/0003-2697(64)90200-3","article-title":"A micro-biuret method for estimating proteins","volume":"9","author":"Ithazaki","year":"1964","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.biopha.2017.03.101_bib0155","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.biopha.2015.12.024","article-title":"The influence of common free radicals and antioxidants on development of Alzheimer's Disease","volume":"78","author":"Wojtunik-Kulesza","year":"2016","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2017.03.101_bib0160","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1093\/ageing\/afs165","article-title":"Evolution of the evidence on the effectiveness and cost-effectiveness of acetylcholinesterase inhibitors and memantine for Alzheimer's disease: systematic review and economic model","volume":"42","author":"Hyde","year":"2013","journal-title":"Age Ageing."},{"key":"10.1016\/j.biopha.2017.03.101_bib0165","doi-asserted-by":"crossref","first-page":"315","DOI":"10.2174\/1570159X11311030006","article-title":"Acetylcholinesterase inhibitors: pharmacology and toxicology","volume":"11","author":"\u010colovi\u0107","year":"2013","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.biopha.2017.03.101_bib0170","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/S0140-6736(82)90429-9","article-title":"Plasma and erythrocyte acetylcholinesterase in senile dementia of Alzheimer type","volume":"8264","author":"Perry","year":"1982","journal-title":"Lancet"},{"key":"10.1016\/j.biopha.2017.03.101_bib0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0022-510X(85)90182-0","article-title":"Blood acetyland butyrylcholinesterases in senile dementia of Alzheimer type","volume":"70","author":"Atack","year":"1985","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.biopha.2017.03.101_bib0180","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/BF01677425","article-title":"Cholinesterases in the cerebrospinal fluid, plasma, and erythrocytes of patients with Alzheimer\u2019s disease","volume":"75","author":"Sirvi\u00f6","year":"1989","journal-title":"J. Neural. Transm."},{"key":"10.1016\/j.biopha.2017.03.101_bib0185","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1212\/WNL.59.4.563","article-title":"Sustained cholinesterase inhibition in AD patients receiving rivastigmine for 12 months","volume":"59","author":"Darreh-Shori","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.biopha.2017.03.101_bib0190","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1177\/000456329002700407","article-title":"Plasma and serum G4 isoenzyme of acetylcholinesterase in patients with Alzheimer-type dementia and vascular dementia","volume":"27","author":"Yamamoto","year":"1990","journal-title":"Ann. Clin. Biochem."},{"key":"10.1016\/j.biopha.2017.03.101_bib0195","doi-asserted-by":"crossref","first-page":"453","DOI":"10.2165\/00002512-200421070-00004","article-title":"Cholinesterase inhibitors used in the treatment of Alzheimer's disease: the relationship between pharmacological effects and clinical efficacy","volume":"21","author":"Wilkinson","year":"2004","journal-title":"Drugs Aging."},{"key":"10.1016\/j.biopha.2017.03.101_bib0200","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/j.1600-0404.2010.01435.x","article-title":"Changes in CSF acetyl- and butyrylcholinesterase activity after long-term treatment with AChE inhibitors in Alzheimer's disease","volume":"124","author":"Parnetti","year":"2011","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.biopha.2017.03.101_bib0205","first-page":"48","article-title":"Plasma acetylcholinesterase activity correlates with intracerebral \u03b2-amyloid load","volume":"10","author":"Alkalay","year":"2013","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.biopha.2017.03.101_bib0210","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0304-3940(01)01586-5","article-title":"Differential increase in cerebrospinal fluid-acetylcholinesterase after treatment with acetylcholinesterase inhibitors in patients with Alzheimer's disease","volume":"300","author":"Davidsson","year":"2001","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.biopha.2017.03.101_bib0215","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1016\/S0047-6374(01)00314-1","article-title":"Cerebrospinal fluid acetylcholinesterase activity after long-term treatment with donepezil and rivastigmina","volume":"122","author":"Amici","year":"2001","journal-title":"Mech. Ageing Dev."},{"key":"10.1016\/j.biopha.2017.03.101_bib0220","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.2174\/1871527313666141023141545","article-title":"Status of acetylcholinesterase and butyrylcholinesterase in Alzheimer's disease and type 2 diabetes mellitus","volume":"13","author":"Mushtaq","year":"2014","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"10.1016\/j.biopha.2017.03.101_bib0225","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/182303","article-title":"The roles of biomarkers of oxidative stress and antioxidant in alzheimer\u2019s disease: a systematic review","author":"Chang","year":"2014","journal-title":"BioMed. Res. Int."},{"key":"10.1016\/j.biopha.2017.03.101_bib0230","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/427318","article-title":"Oxidative stress in alzheimer\u2019s disease: why did antioxidant therapy fail?","author":"Persson","year":"2014","journal-title":"Oxid. Med. and Cell. Long."},{"key":"10.1016\/j.biopha.2017.03.101_bib0235","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0304-3940(00)01433-6","article-title":"A novel acetylcholinesterase inhibitor, attenuates hydrogen peroxide induced injury in PC12 cells","volume":"292","author":"Zhang","year":"2000","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.biopha.2017.03.101_bib0240","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0169-328X(02)00402-3","article-title":"Tacrine attenuates hydrogen peroxide-induced apoptosis by regulating expression of apoptosisrelated genes in rat PC12 cells","volume":"107","author":"Wang","year":"2002","journal-title":"Brain. Res. Mol. Brain Res."},{"key":"10.1016\/j.biopha.2017.03.101_bib0245","doi-asserted-by":"crossref","first-page":"463","DOI":"10.2174\/156720510791383822","article-title":"The serum protein and lipid oxidation marker levels in Alzheimer's disease and effects of cholinesterase inhibitors and antipsychotic drugs therapy","volume":"7","author":"Sinem","year":"2010","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.biopha.2017.03.101_bib0250","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1111\/ggi.12361","article-title":"Ischemia-modified albumin and advanced oxidation protein products as potential biomarkers of protein oxidation in Alzheimer's disease","volume":"15","author":"Altunoglu","year":"2015","journal-title":"Geriatr. Gerontol. Int."},{"key":"10.1016\/j.biopha.2017.03.101_bib0255","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1159\/000339006","article-title":"Ischemia modified albumin and plasma oxidative stress markers in Alzheimer\u2019s disease","volume":"69","author":"Can","year":"2013","journal-title":"Eur. Neurol."},{"key":"10.1016\/j.biopha.2017.03.101_bib0260","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s10238-008-0156-0","article-title":"Relation of plasma protein oxidation parameters and paraoxonase activity in the ageing population","volume":"8","author":"Cakatay","year":"2008","journal-title":"Clin. Exp. Med."},{"key":"10.1016\/j.biopha.2017.03.101_bib0265","series-title":"Aging and Age-Related Disorders, Humana.","first-page":"1","article-title":"Protein redox-regulation mechanisms in aging","author":"\u00c7akatay","year":"2010"},{"key":"10.1016\/j.biopha.2017.03.101_bib0270","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/j.1468-1331.2005.01000.x","article-title":"Study of plasma antioxidant status in Alzheimer\u2019s disease","volume":"12","author":"Pulido","year":"2005","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.biopha.2017.03.101_bib0275","doi-asserted-by":"crossref","first-page":"195","DOI":"10.5507\/bp.2009.032","article-title":"Age-dependent decline in erythrocyte acetylcholinesterase activity: correlation with oxidative stress","volume":"153","author":"Jha","year":"2009","journal-title":"Biomed. Pap. Med. Fac. Univ. Palacky Olomouc Czech Repub."},{"key":"10.1016\/j.biopha.2017.03.101_bib0280","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.neuropharm.2015.02.020","article-title":"Donepezil attenuates A\u03b2-associated mitochondrial dysfunction and reduces mitochondrial A\u03b2 accumulation in vivo and in vitro","volume":"95","author":"Ye","year":"2015","journal-title":"Neuropharm"},{"key":"10.1016\/j.biopha.2017.03.101_bib0285","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/mas.20109","article-title":"Current analytical methods for the detection of dityrosine a biomarker of oxidative stress, in biological samples","volume":"26","author":"DiMarco","year":"2007","journal-title":"Mass Spectrom. Rev."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332217303165?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332217303165?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,2]],"date-time":"2018-09-02T12:30:15Z","timestamp":1535891415000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332217303165"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":57,"alternative-id":["S0753332217303165"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2017.03.101","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The efficacy of donepezil administration on acetylcholinesterase activity and altered redox homeostasis in Alzheimer\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2017.03.101","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}